الملخص
Drug induced leukocytoclastic vasculitis is defined as the inflammation of blood vessels caused by the use of pharmacological agents. It may only affect the skin, resulting in cutaneous leukocytoclastic vasculitis, or it may be systemic, affecting other organs such as central nervous system, gastrointestinal tract, lungs, kidneys, and joints resulting is organ and tissue damage and even death. Early withdrawal of the causative drug is sufficient to promote rapid resolution and recovery. Here we report a case of tigecycline induced cutaneous leukocytoclastic vasculitis of hemorrhagic vesiculobullous type in an immunocompromised patient who was being treated with tigecycline for parapneumonic effusion with persistently elevated inflammatory markers.
الكلمات المفتاحية
بيانات النشر
- المجلة
- مجلة عُمان الطبية, 41(2)
- الناشر
- المجلس العُماني للاختصاصات الطبية
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-NC 4.0
اقتبس هذه المقالة
APA 7
Al Maqbali, H., Al Majrabi, B., Al-Waili, A., Qureshi, A., Balkhair, A., & Al Busaidi, I. (2026). Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation. Oman Medical Journal, 41(2). https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation
MLA 9
Al Maqbali, Huda, et al. "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation." Oman Medical Journal, vol. 41, no. 2, 2026. https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
شيكاغو (المؤلف–التاريخ)
Al Maqbali, Huda, Belkees Al Majrabi, Ahmed Al-Waili, Asim Qureshi, Abullah Balkhair, and Ibrahim Al Busaidi. 2026. "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation." Oman Medical Journal 41 (2). https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
هارفارد
Al Maqbali, H., Al Majrabi, B., Al-Waili, A., Qureshi, A., Balkhair, A. and Al Busaidi, I. (2026) 'Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation', Oman Medical Journal, 41(2). Available at: https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.
فانكوفر
Al Maqbali H, Al Majrabi B, Al-Waili A, Qureshi A, Balkhair A, Al Busaidi I. Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation. Oman Medical Journal. 2026;41(2). https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation
IEEE
H. Al Maqbali, B. Al Majrabi, A. Al-Waili, A. Qureshi, A. Balkhair, and I. Al Busaidi, "Tigecycline Induced Hemorrhagic Vesiculobullous Leukocytoclastic Vasculitis: A Rare Clinical Presentation," Oman Medical Journal, vol. 41, no. 2, 2026, https://omanscience.com/ar/articles/tigecycline-induced-hemorrhagic-vesiculobullous-leukocytoclastic-vasculitis-a-rare-clinical-presentation.